Clinical trial
A Prospective Case-control Validation of Procalcitonin as a Biomarker Diagnosing Pacemaker and Implantable Cardioverter Defibrillator Pocket Infection
NCT05007158 is registered in ClinicalTrials.gov with Deutsches Herzzentrum Muenchen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Case-control Validation of Procalcitonin as a Biomarker Diagnosing Pacemaker and Implantable Cardioverter Defibrillator Pocket Infection
- Lead sponsor
- Deutsches Herzzentrum Muenchen
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2011
- Completion date
- November 1, 2021
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac implantable electronic device infections